Clive Brown
Chief Tech/Sci/R&D Officer bij OXFORD NANOPORE TECHNOLOGIES PLC
Vermogen: 3 M $ op 31-03-2024
Profiel
Clive G. Brown bekleedt de functie van Chief Technology Officer & Director bij Oxford Nanopore Technologies Plc. In het verleden was de heer Brown Director-Information Technology bij Solexa Ltd., Principal bij Oxford GlycoSciences Plc, Consultant bij Wellcome Trust Sanger Institute en Consultant bij Glaxo Wellcome, Inc. Clive G. Brown behaalde een bachelordiploma aan de Universiteit van York.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-01-2024 | 1 720 213 ( 0.20% ) | 3 M $ | 31-03-2024 |
Actieve functies van Clive Brown
| Bedrijven | Functie | Begin |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Chief Tech/Sci/R&D Officer | 01-07-2008 |
Eerdere bekende functies van Clive Brown
| Bedrijven | Functie | Einde |
|---|---|---|
| The SCO Group Ltd. | Director/Board Member | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Corporate Officer/Principal | - |
Solexa Ltd.
 Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Chief Tech/Sci/R&D Officer | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Clive Brown
| The University of York | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| The SCO Group Ltd. |
